Concepedia
Statistics
Publications
12
Citations
358
H-Index
Active since
1995
Affiliations
Johnson & Johnson (United States)(Current)
Novartis (Switzerland)
Idera Pharmaceuticals (United States)
University of Kansas
Steven P. Meduna is an author at Johnson & Johnson (United States) specializing in pharmacology, medicine, and drug discovery.
Top concepts
MedicinePharmacologyDrug DiscoveryBiochemistryNatural SciencesMedicinal ChemistryPharmacotherapyChemical BiologyDrug DevelopmentChemistry
Publications per year
1995–2011
First-in-Class Pan Caspase Inhibitor Developed for the Treatment of Liver Disease
Steven D. Linton, Teresa Aja, Robert A. Armstrong et al. · Journal of Medicinal Chemistry · 2005 · 105 citations
Pathology, Pharmacotherapy, Oxidative Stress +18
Discovery and SAR studies of a novel series of noncovalent cathepsin S inhibitors
Darin J. Gustin, Clark A. Sehon, Jianmei Wei et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 38 citations · Full text
Medicinal Chemistry, Novel Series, Biochemistry +9
Nonpeptidic, Noncovalent Inhibitors of the Cysteine Protease Cathepsin S
Robin L. Thurmond, Mary Pat Beavers, Hui Cai et al. · Journal of Medicinal Chemistry · 2004 · 36 citations · Full text
Protein Chemistry, Medicinal Chemistry, Program Dock +14
Cycloaddition reactions of 1,4-benzoquinone mono- and bisimides with styrenyl systems: New syntheses of nitrogen substituted azapterocarpans, pterocarpans, 2-aryl-2,3-dihydroindoles and -dihydrobenzofurans
Thomas A. Engler, Kenneth O. Lynch, Wenying Chai et al. · Tetrahedron Letters · 1995 · 28 citations
Styrenyl Systems, Engineering, Heterocyclic +6
Pyrazole-based cathepsin S inhibitors with improved cellular potency
Jianmei Wei, Barbara Pio, Hui Cai et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 24 citations · Full text
Medicine, Improved Cellular Potency, Drug Development +3
1–5 of 12